Comment on Why Proteostasis Therapeutics Tumbled 23.2% on Friday

Why Proteostasis Therapeutics Tumbled 23.2% on Friday

After the company reported encouraging early-stage trial data for its cystic fibrosis therapies, shares in Proteostasis Therapeutics (NASDAQ: PTI) skyrocketed yesterday, before retreating 23.2% on Friday. Proteostasis didn't issue any press releases today, so it's likely that the sell-off in its shares was because of investors paring back their positions following its massive move on Thursday.IMAGE SOURCE: GETTY IMAGES.Continue reading

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News